An Evaluation of Polycaprolactone Matrices for Vaginal Delivery of the Antiviral, Tenofovir, in Preventing Heterosexual Transmission of HIV
- 1 October 2013
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 102 (10) , 3725-3735
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Microbicides and HIV prevention: lessons from the past, looking to the futureCurrent Opinion in Infectious Diseases, 2010
- Microbicides for HIV prevention: reality or hope?Current Opinion in Infectious Diseases, 2010
- Pharmaceutical development of microbicide drug productsPharmaceutical Development and Technology, 2009
- Whither or Wither Microbicides?Science, 2008
- Microbicide drug candidates to prevent HIV infectionThe Lancet, 2007
- Cellulose Acetate 1,2-Benzenedicarboxylate Inhibits Infection by Cell-Free and Cell-Associated Primary HIV-1 IsolatesAIDS Research and Human Retroviruses, 2006
- Microbicides to Prevent HIV Transmission: Overcoming Obstacles to Chemical Barrier ProtectionThe Journal of Infectious Diseases, 2006
- Carrageenan Formulation Prevents Macrophage Trafficking from Vagina: Implications for Microbicide Development1Biology of Reproduction, 2003
- Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulationAIDS, 2003